Effects of naltrexone with nicotine replacement on smoking cue reactivity

Preliminary results

Kent E. Hutchison, Peter M. Monti, Damaris J. Rohsenow, Robert M. Swift, Suzanne M. Colby, Maryann Gnys, Raymond Niaura, Alan D. Sirota

Research output: Contribution to journalArticle

Abstract

Although several studies have examined the effects of opioid antagonists on smoking behavior, there have been no reports of the potentially therapeutic combination of naltrexone and nicotine replacement therapy. The primary objective of the present study was to determine whether naltrexone reduced reactivity to smoking cues among abstinent smokers treated with nicotine replacement. Twenty participants were instructed to abstain from smoking cigarettes for 9 h while using nicotine replacement therapy. Participants were subsequently treated with either naltrexone (50 mg) or placebo before being exposed to smoking cues. Results indicated that the smokers who received the placebo responded to smoking cue exposure with increases in urge to smoke and increases in negative affect. Participants who received naltrexone did not show any increase in urge or negative affect and showed a decrease in withdrawal symptoms after exposure to smoking cues. Although preliminary, the findings suggest that naltrexone may work in combination with nicotine replacement therapies to block the effects of smoking stimuli in abstinent smokers.

Original languageEnglish (US)
Pages (from-to)139-143
Number of pages5
JournalPsychopharmacology
Volume142
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Naltrexone
Nicotine
Cues
Smoking
Placebos
Substance Withdrawal Syndrome
Narcotic Antagonists
Therapeutics
Smoke

Keywords

  • Craving
  • Naltrexone
  • Nicotine replacement patch Smoking cue
  • Urge

ASJC Scopus subject areas

  • Pharmacology

Cite this

Hutchison, K. E., Monti, P. M., Rohsenow, D. J., Swift, R. M., Colby, S. M., Gnys, M., ... Sirota, A. D. (1999). Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology, 142(2), 139-143. https://doi.org/10.1007/s002130050872

Effects of naltrexone with nicotine replacement on smoking cue reactivity : Preliminary results. / Hutchison, Kent E.; Monti, Peter M.; Rohsenow, Damaris J.; Swift, Robert M.; Colby, Suzanne M.; Gnys, Maryann; Niaura, Raymond; Sirota, Alan D.

In: Psychopharmacology, Vol. 142, No. 2, 1999, p. 139-143.

Research output: Contribution to journalArticle

Hutchison, KE, Monti, PM, Rohsenow, DJ, Swift, RM, Colby, SM, Gnys, M, Niaura, R & Sirota, AD 1999, 'Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results', Psychopharmacology, vol. 142, no. 2, pp. 139-143. https://doi.org/10.1007/s002130050872
Hutchison, Kent E. ; Monti, Peter M. ; Rohsenow, Damaris J. ; Swift, Robert M. ; Colby, Suzanne M. ; Gnys, Maryann ; Niaura, Raymond ; Sirota, Alan D. / Effects of naltrexone with nicotine replacement on smoking cue reactivity : Preliminary results. In: Psychopharmacology. 1999 ; Vol. 142, No. 2. pp. 139-143.
@article{ef7f4782a0b2459baee3926d93d0fa6d,
title = "Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results",
abstract = "Although several studies have examined the effects of opioid antagonists on smoking behavior, there have been no reports of the potentially therapeutic combination of naltrexone and nicotine replacement therapy. The primary objective of the present study was to determine whether naltrexone reduced reactivity to smoking cues among abstinent smokers treated with nicotine replacement. Twenty participants were instructed to abstain from smoking cigarettes for 9 h while using nicotine replacement therapy. Participants were subsequently treated with either naltrexone (50 mg) or placebo before being exposed to smoking cues. Results indicated that the smokers who received the placebo responded to smoking cue exposure with increases in urge to smoke and increases in negative affect. Participants who received naltrexone did not show any increase in urge or negative affect and showed a decrease in withdrawal symptoms after exposure to smoking cues. Although preliminary, the findings suggest that naltrexone may work in combination with nicotine replacement therapies to block the effects of smoking stimuli in abstinent smokers.",
keywords = "Craving, Naltrexone, Nicotine replacement patch Smoking cue, Urge",
author = "Hutchison, {Kent E.} and Monti, {Peter M.} and Rohsenow, {Damaris J.} and Swift, {Robert M.} and Colby, {Suzanne M.} and Maryann Gnys and Raymond Niaura and Sirota, {Alan D.}",
year = "1999",
doi = "10.1007/s002130050872",
language = "English (US)",
volume = "142",
pages = "139--143",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Effects of naltrexone with nicotine replacement on smoking cue reactivity

T2 - Preliminary results

AU - Hutchison, Kent E.

AU - Monti, Peter M.

AU - Rohsenow, Damaris J.

AU - Swift, Robert M.

AU - Colby, Suzanne M.

AU - Gnys, Maryann

AU - Niaura, Raymond

AU - Sirota, Alan D.

PY - 1999

Y1 - 1999

N2 - Although several studies have examined the effects of opioid antagonists on smoking behavior, there have been no reports of the potentially therapeutic combination of naltrexone and nicotine replacement therapy. The primary objective of the present study was to determine whether naltrexone reduced reactivity to smoking cues among abstinent smokers treated with nicotine replacement. Twenty participants were instructed to abstain from smoking cigarettes for 9 h while using nicotine replacement therapy. Participants were subsequently treated with either naltrexone (50 mg) or placebo before being exposed to smoking cues. Results indicated that the smokers who received the placebo responded to smoking cue exposure with increases in urge to smoke and increases in negative affect. Participants who received naltrexone did not show any increase in urge or negative affect and showed a decrease in withdrawal symptoms after exposure to smoking cues. Although preliminary, the findings suggest that naltrexone may work in combination with nicotine replacement therapies to block the effects of smoking stimuli in abstinent smokers.

AB - Although several studies have examined the effects of opioid antagonists on smoking behavior, there have been no reports of the potentially therapeutic combination of naltrexone and nicotine replacement therapy. The primary objective of the present study was to determine whether naltrexone reduced reactivity to smoking cues among abstinent smokers treated with nicotine replacement. Twenty participants were instructed to abstain from smoking cigarettes for 9 h while using nicotine replacement therapy. Participants were subsequently treated with either naltrexone (50 mg) or placebo before being exposed to smoking cues. Results indicated that the smokers who received the placebo responded to smoking cue exposure with increases in urge to smoke and increases in negative affect. Participants who received naltrexone did not show any increase in urge or negative affect and showed a decrease in withdrawal symptoms after exposure to smoking cues. Although preliminary, the findings suggest that naltrexone may work in combination with nicotine replacement therapies to block the effects of smoking stimuli in abstinent smokers.

KW - Craving

KW - Naltrexone

KW - Nicotine replacement patch Smoking cue

KW - Urge

UR - http://www.scopus.com/inward/record.url?scp=0032932672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032932672&partnerID=8YFLogxK

U2 - 10.1007/s002130050872

DO - 10.1007/s002130050872

M3 - Article

VL - 142

SP - 139

EP - 143

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -